Payments for deferred contingent consideration.

No definition available.

Name:	shpgf_PaymentsForDeferredContingentConsideration
Namespace Prefix:	shpgf_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 25
-Paragraph 23
-URI http://asc.fasb.org/extlink&oid=34752592&loc=d3e1043-128460

+ Details

Name:	us-gaap_BusinessCombinationAcquisitionRelatedCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479

+ Details

Name:	us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessCombinationIntegrationRelatedCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	us-gaap_BusinessAcquisitionAxis=shpgf_DyaxAndBaxaltaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=shpgf_BaxaltaIncorporatedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=shpgf_NpsPharmaceuticalsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=shpgf_LumenaPharmaceuticalsIncAndLotusTissueRepairIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	shpgf_AcquisitionIntegrationCostsAxis=us-gaap_OneTimeTerminationBenefitsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	shpgf_AcquisitionIntegrationCostsAxis=us-gaap_ContractTerminationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Integration and acquisition costs (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Business Acquisition [Line Items]
Integration and acquisition costs	$ 363.0	$ (212.4)	$ 454.1	$ (136.7)
Contingent consideration payments			(4.2)	(4.5)
Baxalta and Dyax
Business Acquisition [Line Items]
Integration and acquisition costs	362.8		453.9
Baxalta
Business Acquisition [Line Items]
Integration and acquisition costs	414.5		442.3
Integration costs	$ 272.9		272.9
NPS Pharma
Business Acquisition [Line Items]
Integration and acquisition costs		47.8		117.7
Lumena and Lotus Tissue Repair
Business Acquisition [Line Items]
Change in fair value of contingent consideration		$ (258.1)		$ (255.7)
Employee termination benefits and other reorganization costs \| Baxalta
Business Acquisition [Line Items]
Integration costs			253.1
R&D program cancelation \| Baxalta
Business Acquisition [Line Items]
Integration costs			$ 12.7